XML 29 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total Shareholders' Equity
Common Shares
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest in Subsidiaries
Noncontrolling Interests in the Operating Partnership
Total
Balance at Dec. 31, 2021 $ 2,871,563 $ 2,239 $ 4,088,392 $ (570) $ (1,218,498) $ 18,597   $ 2,890,160
Balance (in shares) at Dec. 31, 2021   223,918            
Balance of Noncontrolling Interests in the Operating Partnership at Dec. 31, 2021             $ 108,220  
Increase (Decrease) in Stockholders' Equity                
Distributions paid to noncontrolling interest in subsidiaries           (2,033)   (2,033)
Issuance of common shares, net (123)   (123)         (123)
Issuance of restricted shares (in shares)   35            
Conversion from units to shares 21,538 $ 4 21,534       (21,538) 21,538
Conversion from units to shares (in shares)   441            
Exercise of stock options 1,226 $ 1 1,225         1,226
Exercise of stock options (in shares)   40            
Amortization of restricted shares 519   519         519
Share compensation expense 636   636         636
Adjustment for noncontrolling interests in the Operating Partnership 10,356       10,356   (10,356) 10,356
Net income (loss) 38,155       38,155 (181)   37,974
Net income (loss)             292  
Other comprehensive income (loss), net 19     19       19
Other comprehensive income (loss), net             1  
Common share distributions (96,817)       (96,817)   (628) (96,817)
Balance at Mar. 31, 2022 2,847,072 $ 2,244 4,112,183 (551) (1,266,804) 16,383   2,863,455
Balance (in shares) at Mar. 31, 2022   224,434            
Balance of Noncontrolling Interests in the Operating Partnership at Mar. 31, 2022             75,991  
Increase (Decrease) in Stockholders' Equity                
Distributions paid to noncontrolling interest in subsidiaries           (61)   (61)
Issuance of common shares, net (42)   (42)         (42)
Issuance of restricted shares 1 $ 1            
Issuance of restricted shares (in shares)   19            
Amortization of restricted shares 1,373   1,373         1,373
Share compensation expense 635   635         635
Adjustment for noncontrolling interests in the Operating Partnership 13,349       13,349   (13,349) 13,349
Net income (loss) 58,358       58,358 (143)   58,215
Net income (loss)             379  
Other comprehensive income (loss), net 20     20       20
Common share distributions (96,819)       (96,819)   (628) (96,819)
Balance at Jun. 30, 2022 2,823,947 $ 2,245 4,114,149 (531) (1,291,916) 16,179   2,840,125
Balance (in shares) at Jun. 30, 2022   224,453            
Balance of Noncontrolling Interests in the Operating Partnership at Jun. 30, 2022             62,393  
Balance at Dec. 31, 2022 2,826,203 $ 2,246 4,125,478 (491) (1,301,030) 14,178   2,840,381
Balance (in shares) at Dec. 31, 2022   224,603            
Balance of Noncontrolling Interests in the Operating Partnership at Dec. 31, 2022             57,419 57,419
Increase (Decrease) in Stockholders' Equity                
Distributions paid to noncontrolling interest in subsidiaries           (107)   (107)
Issuance of common shares, net (91)   (91)         (91)
Issuance of restricted shares (in shares)   22            
Conversion from units to shares 361   361       (361) 361
Conversion from units to shares (in shares)   8            
Exercise of stock options 915 $ 1 914         915
Exercise of stock options (in shares)   39            
Amortization of restricted shares 1,171   1,171         1,171
Share compensation expense 730   730         730
Adjustment for noncontrolling interests in the Operating Partnership (8,588)       (8,588)   8,588 (8,588)
Net income (loss) 97,566       97,566 (238)   97,328
Net income (loss)             614  
Other comprehensive income (loss), net 20     20       20
Common share distributions (110,524)       (110,524)   (695) (110,524)
Balance at Mar. 31, 2023 2,807,763 $ 2,247 4,128,563 (471) (1,322,576) 13,833   2,821,596
Balance (in shares) at Mar. 31, 2023   224,672            
Balance of Noncontrolling Interests in the Operating Partnership at Mar. 31, 2023             65,565  
Increase (Decrease) in Stockholders' Equity                
Contributions from noncontrolling interest in subsidiaries           797   797
Distributions paid to noncontrolling interest in subsidiaries           (54)   (54)
Issuance of common shares, net (55)   (55)         (55)
Issuance of restricted shares (in shares)   20            
Exercise of stock options 1,801 $ 1 1,800         1,801
Exercise of stock options (in shares)   105            
Amortization of restricted shares 1,621   1,621         1,621
Share compensation expense 692   692         692
Adjustment for noncontrolling interests in the Operating Partnership 2,134       2,134   (2,134) 2,134
Net income (loss) 97,879       97,879 (212)   97,667
Net income (loss)             616  
Other comprehensive income (loss), net 20     20       20
Common share distributions (110,585)       (110,585)   (695) (110,585)
Balance at Jun. 30, 2023 $ 2,801,270 $ 2,248 $ 4,132,621 $ (451) $ (1,333,148) $ 14,364   2,815,634
Balance (in shares) at Jun. 30, 2023   224,797            
Balance of Noncontrolling Interests in the Operating Partnership at Jun. 30, 2023             $ 63,352 $ 63,352